These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7968283)

  • 1. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S; Uchida H; Yoshikawa K; Fujita N; Ohtomo K; Yuasa Y; Kawamura Y; Matsui O
    Magn Reson Imaging; 1994; 12(6):837-46. PubMed ID: 7968283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MR imaging oral contrast agent mixed with milk for the small intestine].
    Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
    Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
    Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen.
    Malcolm PN; Brown JJ; Hahn PF; Stillman AE; Li KC; Kawamura Y; Tanaka T; Noel JK; Molony BA; Johnson MF; Hildebolt CF
    J Magn Reson Imaging; 2000 Nov; 12(5):702-7. PubMed ID: 11050639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elimination of bowel fluid artifact on abdominal DWI using oral contrast agent ferric ammonium citrate].
    Takahashi T; Kato K; Nishizawa T; Nakazawa Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2008 May; 64(5):573-8. PubMed ID: 18509218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
    Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
    Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New development of cellulose-ferric ammonium citrate solution as a contrast-enhancement agent for magnetic resonance imaging of esophageal diseases].
    Ogawa Y; Noda Y; Sawada A; Fujiwara Y; Hamada N; Terashima M; Inomata T; Yoshida S; Morio K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1178-80. PubMed ID: 9261198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
    Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
    Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contrast media for magnetic resonance tomography of the abdomen. 1. Comparative animal studies of positive and negative contrast media].
    Laniado M; Kaminsky S; Semmler W; Weinmann HJ; Zurth C; Claussen C
    Rofo; 1987 Sep; 147(3):325-32. PubMed ID: 2445010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferrimagnetic susceptibility contrast agents.
    Bach-Gansmo T
    Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal MRI using a negative contrast agent.
    Bach-Gansmo T; Dupas B; Gayet-Delacroix M; Lambrechts M
    Br J Radiol; 1993 May; 66(785):420-5. PubMed ID: 8319063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent.
    Unger EC; Fritz TA; Palestrant D; Meakem TJ; Granstrom P; Gatenby RA
    J Magn Reson Imaging; 1993; 3(1):119-24. PubMed ID: 8428077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.